Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were first detected in Wuhan, China in December 2019 and resulted in a worldwide pandemic in 2020. SARS-CoV-2 infections totalled more than 180 million with 3.9 million deaths as of June 24, 2021. Tremendous research efforts hav...

Full description

Bibliographic Details
Main Authors: Hui Xuan Lim, Masita Arip, Abdul Aziz Al-Fattah Yahaya, Seyed Davoud Jazayeri, Sibrandes Poppema, Chit Laa Poh
Format: Article
Language:English
Published: IMR Press 2021-11-01
Series:Frontiers in Bioscience-Landmark
Subjects:
immunogenicity
safety
sars-cov-2
vaccines
Online Access:https://www.imrpress.com/journal/FBL/26/11/10.52586/5024

Similar Items

Similar Items